Albuminuria News and Research

RSS
Albuminuria also called proteinuria or urine albumin—is a condition in which urine contains an abnormal amount of protein. Albumin is the main protein in the blood. Proteins are the building blocks for all body parts, including muscles, bones, hair, and nails. Proteins in the blood also perform a number of important functions. They protect the body from infection, help blood clot, and keep the right amount of fluid circulating throughout the body.

Further Reading

First European approval of drug to treat genetic kidney disease ADPKD

First European approval of drug to treat genetic kidney disease ADPKD

New Johns Hopkins-led research suggests risk factors for developing acute kidney injury

New Johns Hopkins-led research suggests risk factors for developing acute kidney injury

Blood pressure-lowering treatment lowers CVD, heart disease risks among type 2 diabetes patients

Blood pressure-lowering treatment lowers CVD, heart disease risks among type 2 diabetes patients

Ardelyx announces positive Phase 2b results for tenapanor in IBS-C patients

Ardelyx announces positive Phase 2b results for tenapanor in IBS-C patients

Albuminuria change is a strong cardiovascular risk indicator in diabetes

Albuminuria change is a strong cardiovascular risk indicator in diabetes

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

New research uncovers abnormal molecular signaling pathways for kidney failure

New research uncovers abnormal molecular signaling pathways for kidney failure

New study examines factors that may lead to end stage renal disease

New study examines factors that may lead to end stage renal disease

NOXXON Pharma reports interim data from two phase IIa studies of anti-CXCL12/SDF-1 Spiegelmer NOX-A12

NOXXON Pharma reports interim data from two phase IIa studies of anti-CXCL12/SDF-1 Spiegelmer NOX-A12

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

New evidence shows particulate matter exposure associated with kidney damage

New evidence shows particulate matter exposure associated with kidney damage

Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy

Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy

Urinary protein may be early warning sign regarding patients' cognitive abilities

Urinary protein may be early warning sign regarding patients' cognitive abilities

High levels of urinary albumin-to-creatinine ratio linked with greater risk of CHD in black individuals

High levels of urinary albumin-to-creatinine ratio linked with greater risk of CHD in black individuals

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

CKD may raise risk of mortality and end stage renal disease for both men and women

CKD may raise risk of mortality and end stage renal disease for both men and women

BPA adversely affects kidney function in children

BPA adversely affects kidney function in children

CYP2J2 implicated in preeclampsia

CYP2J2 implicated in preeclampsia

CYP2J2 implicated in preeclampsia

CYP2J2 implicated in preeclampsia